Business Wire

Eurosets Presents Colibrì, the Lightest and Most Compact ECLS System in the Market Which May Be Transported Even in a Backpack


Eurosets, a company based in Medolla (Italy) leader in the development, production, and commercialization of advanced medical devices, announced during the 36th European Association for Cardiothoracic Surgery (EACTS) annual meeting (Milan, 5th-8th October 2022) the launch of Colibrì, the lightest extracorporeal life support (ECLS) system available in the market.

This press release features multimedia. View the full release here:

To view this piece of content from, please give your consent at the top of this page.

Ettore Sansavini, Eurosets President, and Antonio Petralia, Eurosets CEO, next to the Colibrì (Photo: Business Wire)

Colibrì complements and expands Eurosets ECLS portfolio with the objective to provide temporary support to patients suffering from ventricular failure, cardiac arrest, or respiratory failure in a variety of different applications, including extracorporeal membrane oxygenation (ECMO), extracorporeal cardiopulmonary resuscitation (E-CPR), and mechanical circulatory support (MCS).

Featuring a fully magnetic-levitating centrifugal pump that covers adult, paediatric and new-born patients, a series of advanced monitoring capabilities, and a complete integration with ECMOLife, Colibrì is the lightest device available in the market. The breakthrough device developed by Eurosets is also the only one equipped with a wi-fi connection that allows innovative remote monitoring, thereby ensuring greater patient safety and easier management for healthcare professionals. In addition to that, a set of unique transport accessories, designed to perform ECLS even in the most difficult scenarios, makes Colibrì the only device available in the market truly able to perform ECLS treatments everywhere there is a life to save.

"Two years after the successful launch of ECMOLife, that supported more than 3.000 critically ill patients in more than 40 countries worldwide, Eurosets portfolio expands with the launch of Colibrì, an innovative system with the potential to revolutionize the standard of care," said Antonio Petralia, CEO and Executive Vice President of Eurosets. "Our vision is to reimagine ECLS treatments while responding to diverse medical needs through meaningful innovation and Colibrì is fully in line with these core beliefs."

Colibrì is currently being introduced in a selected number of European centers as part of a controlled launch, after which a full international commercial release will follow upon achievement of local approvals.

For more information about Colibrì please contact your local Eurosets representative or visit site.

To view this piece of content from, please give your consent at the top of this page.

Contact information

Eurosets Press Office

About Business Wire

Business Wire
Business Wire

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

EODev Launches a New Range of High Capacity Zero-emission Hydrogen Power Generators6.12.2022 15:18:00 CET | Press release

After less than three years in business and close to 100 GEH2® (110kVA) and onboard REXH2®(70kW) electro-hydrogen power generators sold across the world, French manufacturer EODev announces the commercialization of new products from 10kVA to 1,750kVA. The first models will enter production in 2024 and will be available for order from mid-2023. EODev's assembly line near Paris already delivers one 110kVA GEH2® per day. The objective being to avoid the emission of 30 million tons of CO2 over the next 10 years, EODev now initiates the second phase of its product development by expanding its range to offer new high power "plug & play" solutions for existing customers, such as equipment rental leaders Loxam and United Rentals, and for new markets with high power back up or fast EV charging in mind. The acceleration of our deployment continues. We have proven the validity of our products throughout the world and built a leading know-how in the design and management of fuel cell systems over

Rimini Street Launches Rimini Connect™ to Help Organizations Future-Proof and Solve Continuously Evolving and Growing Integration and Interoperability Challenges6.12.2022 15:01:00 CET | Press release

Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products, and a Salesforce partner, has launched Rimini Connect™, a new suite of integration and interoperability solutions that allows for easy resolution of continuously changing integration and interoperability requirements. This press release features multimedia. View the full release here: Rimini Street announced launch of Rimini Connect™, a new suite of integration and interoperability solutions that allows for easy resolution of continuously changing integration and interoperability requirements. (Graphic: Business Wire) For years, Rimini Street has provided proven and proactive integration and interoperability solutions for its clients’ enterprise software applications, browsers, infrastructure, and email. Three initial solutions are now being brought tog

Gurobi’s Expert-Led Team Provides In-Depth Technical Guidance and Support6.12.2022 15:00:00 CET | Press release

Gurobi Optimization, LLC, the leader in decision intelligence technology and creator of the world’s fastest mathematical optimization solver, recently announced the rebranding of its support team as “Gurobi Experts – Technical Advisory and Support Team.” This team of 15+ PhD-level optimization specialists is passionate about helping customers succeed with optimization and can provide comprehensive guidance on Gurobi products and mathematical optimization. Matthias Miltenberger, Optimization Support Manager, explained that the reasoning behind the rebrand stemmed from some common misunderstandings about the word “support.” “There’s this idea that ‘support’ means sitting in a call center all day with headphones on,” said Miltenberger. “Most people hear that word and think of experiences they’ve had calling up their phone or internet provider, which are often unpleasant experiences. And the assumption is that they’re not really talking to experts, so we definitely wanted to change that mi

Mavenir Wins Most Innovative Cloud Product Award for Telco Cloud Solution from Light Reading6.12.2022 15:00:00 CET | Press release

Mavenir, the Network Software Provider building the future of networks with cloud-native software that runs on any cloud and transforms the way the world connects, has won the Most Innovative Cloud Product Award from Leading Lights for its Telco Cloud Solution. Mavenir’s Telco cloud solution provides CSPs a complete, end-to-end network software portfolio that is 100% cloud-native and runs in any cloud environment private, public, and hybrid. Cloud-native is required to support the 5G heterogenous environment in an automated manner, with microservices implemented in containers providing the placement of workloads at the right location. “Mavenir’s cloud-first approach to networks is recognized as a path to the future,” said Bejoy Pankajakshan, EVP, Chief Technology and Strategy Officer at Mavenir. “We are empowering operators to take full advantage of cloud technology with reliable, carrier-grade, high-performance solutions with security and on-demand scaling.” Mavenir’s solution is uniq

Medidata Launches New myMedidata Native App to Expedite Study Start Up and Improve Patient Experience6.12.2022 15:00:00 CET | Press release

Medidata, a Dassault Systèmes company, launched a new patient-centric native myMedidata app, designed to provide trial participants with another option for a seamless platform experience and a single login for all their remote trial activities. The app will feature all of the myMedidata patient-centric solutions, with an initial focus on eCOA (electronic clinical outcome assessments). The myMedidata app is available on iOS and Android and can be used both on the patients’ own devices (BYOD) or via a provisioned device. “Our latest addition to myMedidata brings an innovative app to patients designed in concert with our patient insights team, customer feedback, and the experiences derived from running the world’s biggest DCTs over the last twenty years,” said Matt Noble, senior vice president, Medidata Patient Cloud. “Medidata is leveraging its unique insights from sponsors, CROs, sites, and patients to make a meaningful difference in the clinical trial experience.” Unique to the industr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom